Deira Trading Company


Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

Leave a Reply

Your email address will not be published. Required fields are marked *

Source: CurrencyRate